Extended-release carbamazepine capsules in the treatment of bipolar I disorder

被引：0

作者：

Kalali, A

Weisler, R

机构：

[1] Univ Calif San Diego, San Diego, CA 92103 USA

[2] Univ N Carolina, Chapel Hill, NC 27515 USA

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S397 / S397

页数：1

共 50 条

[31] Efficacy of dexmethylphenidate extended-release capsules in adults with attentiondeficit/hyperactivity disorder
Spencer, T
McGough, J
Muniz, R
Pestreich, L
Kim, S
Jiang, H
Agoropoulou, C
Etropolski, M
[J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (04) : 515 - 516
[32] Transitioning from immediate-release to extended-release carbamazepine capsules: Medication preference and increased compliance
Moore, JL
[J]. EPILEPSIA, 2005, 46 : 214 - 215
[33] Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients
Childress, Ann
Sottile, Robert
Khanbijian, Sherine
[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (11) : 945 - 953
[34] Venlafaxine extended-release treatment of hoarding disorder
Saxena, Sanjaya
Sumner, Jennifer
[J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (05) : 266 - 273
[35] Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder
Tatia Chay Woodward
Eskinder Tafesse
Peter Quon
Arthur Lazarus
[J]. PharmacoEconomics, 2010, 28 : 751 - 764
[36] Simulated fluctuations in plasma drug concentrations for patients receiving oxcarbazepine or carbamazepine extended-release capsules
Ahmad, A
Garnett, WR
[J]. CLINICAL DRUG INVESTIGATION, 2005, 25 (10) : 669 - 673
[37] Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder
Woodward, Tatia Chay
Tafesse, Eskinder
Quon, Peter
Lazarus, Arthur
[J]. PHARMACOECONOMICS, 2010, 28 (09) : 751 - 764
[38] Simulated Fluctuations in Plasma Drug Concentrations for Patients Receiving Oxcarbazepine or Carbamazepine Extended-Release Capsules
Alaa Ahmad
William R. Garnett
[J]. Clinical Drug Investigation, 2005, 25 : 669 - 673
[39] Switching to extended-release carbamazepine capsules from immediate-release formulations: Evaluation of medication satisfaction and preference
Moore, JL
[J]. NEUROLOGY, 2005, 64 (06) : A118 - A118
[40] Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents
Maletic, Vladimir
Mattingly, Gregory W.
Earnest, Jami
[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (05) : 443 - 455

← 1 2 3 4 5 →